SANN.SW
Santhera Pharmaceuticals Holding AG
Price:  
9.89 
CHF
Volume:  
157,507.00
Switzerland | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SANN.SW WACC - Weighted Average Cost of Capital

The WACC of Santhera Pharmaceuticals Holding AG (SANN.SW) is 6.1%.

The Cost of Equity of Santhera Pharmaceuticals Holding AG (SANN.SW) is 6.70%.
The Cost of Debt of Santhera Pharmaceuticals Holding AG (SANN.SW) is 5.10%.

Range Selected
Cost of equity 4.60% - 8.80% 6.70%
Tax rate 0.50% - 1.00% 0.75%
Cost of debt 4.00% - 6.20% 5.10%
WACC 4.4% - 7.8% 6.1%
WACC

SANN.SW WACC calculation

Category Low High
Long-term bond rate 1.0% 1.5%
Equity market risk premium 5.1% 6.1%
Adjusted beta 0.71 1.12
Additional risk adjustments 0.0% 0.5%
Cost of equity 4.60% 8.80%
Tax rate 0.50% 1.00%
Debt/Equity ratio 0.6 0.6
Cost of debt 4.00% 6.20%
After-tax WACC 4.4% 7.8%
Selected WACC 6.1%